Literature DB >> 9311022

The D3 dopamine receptor: neurobiology and potential clinical relevance.

B Levant1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9311022

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  96 in total

1.  Role of Gα(12)- and Gα(13)-protein subunit linkage of D(3) dopamine receptors in the natriuretic effect of D(3) dopamine receptor in kidney.

Authors:  Ye Zhang; Chunjiang Fu; Laureano D Asico; Van Anthony M Villar; Hongmei Ren; Duofen He; Zhen Wang; Jian Yang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertens Res       Date:  2011-06-02       Impact factor: 3.872

2.  Clinical and imaging features of Othello's syndrome.

Authors:  J Graff-Radford; J L Whitwell; Y E Geda; K A Josephs
Journal:  Eur J Neurol       Date:  2011-04-25       Impact factor: 6.089

3.  Coupling of dopamine receptors to G proteins: studies with chimeric D2/D3 dopamine receptors.

Authors:  Tal Ilani; C Simone Fishburn; Berta Levavi-Sivan; Shari Carmon; Lily Raveh; Sara Fuchs
Journal:  Cell Mol Neurobiol       Date:  2002-02       Impact factor: 5.046

4.  CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist.

Authors:  Jianyong Chen; Gregory T Collins; Beth Levant; James Woods; Jeffrey R Deschamps; Shaomeng Wang
Journal:  ACS Med Chem Lett       Date:  2011-08-11       Impact factor: 4.345

5.  Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study.

Authors:  Robert H Mach; Zhude Tu; Jinbin Xu; Shihong Li; Lynne A Jones; Michelle Taylor; Robert R Luedtke; Colin P Derdeyn; Joel S Perlmutter; Mark A Mintun
Journal:  Synapse       Date:  2011-03-21       Impact factor: 2.562

6.  The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.

Authors:  Arlene C Pak; Charles R Ashby; Christian A Heidbreder; Maria Pilla; Jeremy Gilbert; Zheng-Xiong Xi; Eliot L Gardner
Journal:  Int J Neuropsychopharmacol       Date:  2006-08-31       Impact factor: 5.176

7.  Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.

Authors:  Mark J Millan; Loretta Iob; Jean-Louis Péglion; Anne Dekeyne
Journal:  Psychopharmacology (Berl)       Date:  2006-09-19       Impact factor: 4.530

8.  Influence of cocaine history on the behavioral effects of Dopamine D(3) receptor-selective compounds in monkeys.

Authors:  B L Blaylock; R W Gould; A Banala; P Grundt; R R Luedtke; A H Newman; M A Nader
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

9.  Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats.

Authors:  Zheng-Xiong Xi; Jeremy Gilbert; Arlene C Campos; Nicole Kline; Charles R Ashby; Jim J Hagan; Christian A Heidbreder; Eliot L Gardner
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

10.  The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats.

Authors:  Krista Spiller; Zheng-Xiong Xi; Xiao-Qing Peng; Amy H Newman; Charles R Ashby; Christian Heidbreder; József Gaál; Eliot L Gardner
Journal:  Psychopharmacology (Berl)       Date:  2007-11-06       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.